ALA Diagnostics is a biotechnological start up that operates in the Healthcare Market and whose objectives are to become a developer and marketer of solutions for the diagnosis of pathologies with high prevalence and / or unmet medical needs.
ALA Diagnostics rises as a result of the identification of an opportunity for the development of a Multiple Sclerosis diagnostic kit, based on a patented recombinant protein and whose activity as a diagnostic biomarker has already been validated in 598 human samples.
It is the only clinically validated specific biomarker for the diagnosis of Multiple Sclerosis in blood. It is a rapid, simple, inexpensive, non-invasive diagnostic test, applicable to early diagnosis of the disease and easy to integrate into clinical routine.
ALA Diagnostics´ pipeline is based on products designed by clinical teams to solve the deficiencies that they find in the course of their care activity.

ALA Diagnostics

Org chart

Teams

Offices